Ascendis Pharma (ASND) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Ascendis Pharma, as the data feed reports them.

Analysts' mean target, 21 analysts
$315.84
16.8% above the price

The 21 analysts reported by the data feed have a mean price target for Ascendis Pharma of $315.84, 16.8% above the $270.31 price (range $272.79–$354.43). 5.41% of the float was sold short as of Oct 30, 2026. Institutions hold 104.7% of the shares and insiders 0.8%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$315.84+16.8% vs price
Analysts
21
Short interest
5.41%of float, Oct 30, 2026
Short ratio
4.24 days
Institutions
104.7%
Insiders
0.79%

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

21 analysts covering Ascendis Pharma, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $270.31.

Analysts' price targets for Ascendis Pharma
Mean price target$315.8416.8% above the price (+16.8%)
Median price target$314.2716.3% above the price (+16.3%)
Highest target$354.4331.1% above the price (+31.1%)
Lowest target$272.790.9% above the price (+0.9%)
Analysts with a target21

Ratings this month · 21 analysts

Strong buy 5(24%)Buy 15(71%)Hold 1(5%)
Analysts' ratings of Ascendis Pharma this month, by rating
RatingAnalystsShare
Strong buy524%
Buy1571%
Hold15%
Sell00%
Strong sell00%

The feed averages these to 1.33 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Ascendis Pharma

Ownership of Ascendis Pharma
Held by institutions104.7%487 institutions; percent of shares outstanding
Held by institutions, of the float105.5%
Held by insiders0.79%percent of shares outstanding
Shares outstanding65.6M
Float65.56Mshares available to trade
Insiders' net purchases, six months+3.01K6 purchases (6.25K shares), 2 sales (3.24K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Ascendis Pharma
Shares short3Mas of Oct 30, 2026
Percent of float5.41%shares short ÷ float
Percent of shares outstanding4.57%shares short ÷ shares outstanding
Short ratio (days to cover)4.24shares short ÷ average daily volume

Ascendis Pharma short interest from FINRA, with its history

Trading figures

Trading figures for Ascendis Pharma
52-week high$282.15
52-week low$188.08
Average volume, 3 months737.57Kshares a day
Average volume, 10 days830.15Kshares a day

Questions and answers

What is the analysts' price target for Ascendis Pharma (ASND)?

As reported by the data feed, the mean price target of the 21 analysts covering Ascendis Pharma is $315.84, 16.8% above the latest price of $270.31. The highest target is $354.43 and the lowest $272.79. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Ascendis Pharma stock?

Of the 21 ratings the data feed reports for the current month, 5 are strong buy, 15 buy, 1 hold, 0 sell and 0 strong sell.

How many Ascendis Pharma shares are sold short?

As reported by the data feed, 3M shares were sold short, 5.41% of the float as of Oct 30, 2026. At the average daily volume that is 4.24 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Ascendis Pharma stock?

As reported by the data feed, institutions hold 104.7% of the shares (487 institutions) and insiders 0.8%. There are 65.6M shares outstanding, of which 65.56M are in the float.

Cite this page

Funkfolio, “Ascendis Pharma (ASND) statistics: analyst targets and short interest”, data as of 17 November 2026. https://funkfolio.com/stock/ASND/statistics

Underlying data: Yahoo Finance.